Optical Coherence Tomography Evaluation of Retinoschisis and Retinal Detachment
NCT ID: NCT02682797
Last Updated: 2016-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2013-09-30
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore exact diagnosis of retinoschisis and retinal detachment has to be assessed and regular follow-up controls have to be conducted for sufficient recognition of progression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Unveiling Preclinical Idiopathic Macular Hole Formation
NCT02180633
High Resolution Optical Coherence Tomography
NCT05130385
Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy
NCT01862627
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
NCT06023446
Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases
NCT02683694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
At all study visits a complete ophthalmic examination, visual acuity and refractive error, Spectralis OCT, Cirrus OCT, Topcon OCT, PS-OCT, Optomap Fundus photography will be performed.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ophthalmoscopic evidence of RS or RD
* Written informed consent has been obtained.
Exclusion Criteria
* Contraindication to pupil dilation, known allergy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefan Sacu
Assoc. Prof. PD. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Medical University of Vienna, Austria
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19.08.2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.